Kymera Therapeutics, Inc.
KYMR
24 insider filings · Latest: May 11, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Mar 4 11:00 PM | Jared GollobChief Medical Officer | Sale | 5,613 | $88.93 | $499.1K | 122,029(D) | View → |
| Mar 4, 2026 | Mar 4 11:00 PM | Bruce N. JacobsChief Financial Officer | Sale | 4,895 | $85.30 | $417.5K | 232,588(D) | View → |
| Mar 2, 2026 | Mar 4 11:00 PM | Bruce N. JacobsChief Financial Officer | Sale | 7,576 | $88.93 | $673.7K | 237,483(D) | View → |
| Mar 2, 2026 | Mar 4 9:30 PM | Bruce BoothDirector | Sale | 81,866 | $90.13 | $7.4M | 675,341(I) | View → |
| Mar 2, 2026 | Mar 2 10:11 PM | Atlas Venture Opportunity Fund I, LP | Proposed Sale | 25,000 | $91.35 | $2.3M | — | View → |
| Mar 2, 2026 | Mar 2 10:11 PM | Atlas Venture Fund X, LP | Proposed Sale | 200,000 | $91.35 | $18.3M | — | View → |
| Mar 2, 2026 | Mar 2 10:08 PM | Gollob Jared | Proposed Sale | 10,613 | $90.10 | $956.2K | — | View → |
| Mar 2, 2026 | Mar 2 10:07 PM | Chadwick Jeremy G | Proposed Sale | 6,206 | $90.10 | $559.2K | — | View → |
| Mar 2, 2026 | Mar 2 10:06 PM | Jacobs Bruce N. | Proposed Sale | 12,576 | $90.10 | $1.1M | — | View → |
| Feb 25, 2026 | Feb 25 10:24 PM | Nello MainolfiDirector, Chief Executive Officer | Sale | 30,000 | $90.26 | $2.7M | 666,195(D) | View → |
| Feb 25, 2026 | Feb 25 9:03 PM | Mainolfi Nello | Proposed Sale | 30,000 | $91.40 | $2.7M | — | View → |
| Feb 20, 2026 | Feb 20 10:30 PM | Pamela EspositoDirector | Sale | 2,500 | $87.31 | $218.3K | 0(D) | View → |
| Feb 20, 2026 | Feb 20 9:28 PM | PAMELA ESPOSITO | Proposed Sale | 2,500 | $86.50 | $216.3K | — | View → |
| Jan 20, 2026 | Jan 20 11:30 PM | Pamela EspositoDirector | Sale | 5,500 | $67.91 | $373.5K | 0(D) | View → |
| Jan 20, 2026 | Jan 20 9:29 PM | PAMELA ESPOSITO | Proposed Sale | 5,500 | $69.54 | $382.5K | — | View → |
| Dec 31, 2025 | Dec 31 10:23 PM | Nello MainolfiDirector, Chief Executive Officer | Sale | 30,000 | $78.06 | $2.3M | 663,077(D) | View → |
| Dec 31, 2025 | Dec 31 9:06 PM | Mainolfi Nello | Proposed Sale | 30,000 | $77.69 | $2.3M | — | View → |
| Dec 17, 2025 | Dec 17 9:23 PM | PAMELA ESPOSITO | Proposed Sale | 27,563 | $84.19 | $2.3M | — | View → |
| Dec 12, 2025 | Dec 12 10:20 PM | Atlas Venture Opportunity Fund I, L.P. | Proposed Sale | 108 | $89.68 | $9.7K | — | View → |
| Dec 12, 2025 | Dec 12 10:08 PM | Atlas Venture Fund X, L.P. | Proposed Sale | 570 | $89.68 | $51.1K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Mar 4 11:00 PM | Jared GollobChief Medical Officer | Grant/Award | 35,300 | $90.10 | 35,300(D) | View → |
| Mar 2, 2026 | Mar 4 11:00 PM | Bruce N. JacobsChief Financial Officer | Grant/Award | 35,300 | $90.10 | 35,300(D) | View → |
| Mar 2, 2026 | Mar 4 11:00 PM | Nello MainolfiDirector, Chief Executive Officer | Grant/Award | 215,000 | $90.10 | 215,000(D) | View → |
| Feb 25, 2026 | Feb 25 10:24 PM | Nello MainolfiDirector, Chief Executive Officer | Option Exercise | 30,000 | $2.08 | 245,559(D) | View → |
| Feb 20, 2026 | Feb 20 10:30 PM | Pamela EspositoDirector | Option Exercise | 2,500 | $49.10 | 2,500(D) | View → |
| Jan 20, 2026 | Jan 20 11:30 PM | Pamela EspositoDirector | Option Exercise | 5,500 | $49.10 | 5,000(D) | View → |
| Dec 31, 2025 | Dec 31 10:23 PM | Nello MainolfiDirector, Chief Executive Officer | Option Exercise | 30,000 | $2.08 | 275,559(D) | View → |
← Previous
Page 2 of 2